Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas
Authors:
- 22 February 2010
- journal article
- Published by Wiley in Histopathology
- Vol. 56 (3) , 364-371
Abstract
Mankey C C, McHugh J B, Thomas D G & Lucas D R (2010) Histopathology 56, 364–371 Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas Aims: The term lymphangiosarcoma has largely been abandoned in the current classification of endothelial neoplasms. Recently, a number of lymphatic‐associated antibodies have been developed for immunohistochemistry, which frequently stain angiosarcomas, implying lymphatic or mixed lymphatic and blood vascular differentiation is common. The aim was to investigate further lymphatic antigen expression, and to explore the relation of immunohistochemistry to morphological and clinical findings.Methods and results: Forty‐nine angiosarcomas in tissue microarrays were analysed with D2‐40 and antibodies to Prox‐1 and vascular endothelial growth factor receptor (VEGFR)‐3. D2‐40 was positive in 53%, Prox‐1 in 76%, and VEGFR‐3 in 57%. Tumours with features attributable to lymphatic differentiation such as hobnail and kaposiform morphologies were more often positive with these markers, including a statistical association between D2‐40 and hobnailing. Ten tumours had features suggestive of lymphatic differentiation, namely well‐differentiated histology, interanastomosing channels devoid of red cells, prominent hobnailing, lymphoid aggregates, and multi‐antigen expression of D2‐40 (100%), Prox‐1 (100%) and VEGFR‐3 (60%), which might be deserving of the appellation lymphangiosarcoma. Nine were cutaneous scalp/facial tumours in elderly patients and one arose within chronic lymphoedema.Conclusions: Lymphatic differentiation is common in angiosarcoma, certain subsets show greater lymphatic differentiation than others, and lymphangiosarcoma may be defined pathologically, rather than clinically.Keywords
This publication has 18 references indexed in Scilit:
- Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomasJournal of Surgical Oncology, 2007
- Usefulness of D2‐40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angiomaJournal of Cutaneous Pathology, 2006
- D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendotheliomaLaboratory Investigation, 2005
- Molecular lymphangiogenesis: new playersTrends in Cell Biology, 2005
- Expression of D2‐40 in lymphatic endothelium of normal tissues and in vascular tumoursHistopathology, 2005
- Identification of Lymphatic Endothelium in Pediatric Vascular Tumors and MalformationsPediatric and Developmental Pathology, 2005
- Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of AngiosarcomasLaboratory Investigation, 2000
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999
- Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular TumorsThe American Journal of Pathology, 1998
- The histogenesis of angiosarcoma of the face and scalp: an immunohistochemical and ultrastructural studyHistopathology, 1987